Clinical Relevance of the Dose of Cytarabine in the Upfront Treatment of Primary CNS Lymphomas with Methotrexate-Cytarabine Combination

BACKGROUND. The combination of high doses of methotrexate (MTX) and cytarabine (araC) is the standard chemotherapy for patients with primary CNS lymphoma (PCNSL). The addition of an alkylating agent could improve MTX-araC efficacy because it is active against quiescent G0 cells and increases antimet...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Ferreri, Andrés J. M., Licata, Giada, Foppoli, Marco, Corazzelli, Gaetano, Zucca, Emanuele, Stelitano, Caterina, Zaja, Francesco, Fava, Sergio, Paolini, Rossella, Franzin, Alberto, Politi, Letterio S., Ponzoni, Maurilio, Reni, Michele
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: AlphaMed Press 2011
Konular:
Lymphoma
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3228098/
https://ncbi.nlm.nih.gov/pubmed/21346023
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2010-0361
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller